Neurology
Feature
Protean manifestations of COVID-19: “Our ignorance is profound”
“Make sure they didn’t die in vain.”
News
FDA approves Koselugo for pediatric neurofibromatosis treatment
News
Neurologists navigate unknown territory during COVID-19 pandemic
Potentially relevant drug interactions, how immunosuppressive medications may influence the risk of COVID-19, and neurologic diseases that may be...
Opinion
The power and promise of person-generated health data (Part II)
While PGHD has the potential to help people, it also presents new challenges.
Latest News
Due to the COVID-19 pandemic, the AAN urges feds to further expand telehealth benefits
According to the AAN, the easing of restrictions on telehealth should be extended beyond Medicare fee-for-service to both Medicare Advantage and...
Feature
New ASAM guideline released amid COVID-19 concerns
During the COVID-19 pandemic, “it is especially important” for clinicians to ensure that individuals with OUD continue to receive evidence-based...
Conference Coverage
Manual dexterity may decline more rapidly in pediatric-onset MS
WEST PALM BEACH, FLA. – Age, sex, Patient-Determined Disease Steps, and multiple sclerosis type significantly affect...
Article
Pediatrics Board Review: Neonatal Seizures
News
AAN publishes guideline on the treatment of sleep problems in children with autism
Behavioral strategies should be the first-line treatment, and clinicians should offer melatonin if these strategies are not helpful, according to...
From the Journals
Pharmacologic prophylaxis fails in pediatric migraine
A network meta-analysis of pharmacologic prophylaxis shows little evidence for efficacy in children.
Conference Coverage
EEG abnormalities may indicate increased risk for epilepsy in patients with autism
BALTIMORE – A family history of febrile seizures, but not a patient’s history of febrile seizures, was associated...